Clinical trial Recruiting at 1 site Interventional Ages 45 to 65

Goal setting to increase physical activity in midlife adults

Official title: Goal Setting to Promote Physical Activity Adherence in Midlife to Reduce Risk of Alzheimer's Disease and Related-Dementias: A Randomized Mechanistic Proof-Of-Concept Trial

Run by Arizona State University · NCT05980052 · Data updated 2026-11-12

This study is testing different goal-setting methods to help midlife adults with obesity become more active and reduce their risk of Alzheimer's disease.

Quick facts

Study typeInterventional
Ages45 Years to 65 Years
SexAll
Enrollment144 (estimated)
SponsorArizona State University
Academic / other
Locations1 site (Phoenix, Arizona)
StatusRecruiting
StartedJuly 17, 2023
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJuly 17, 2026
Trial IDNCT05980052 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are midlife adults aged 45 to 65 with a BMI between 30 and 50 who engage in less than 60 minutes of moderate-to-vigorous physical activity per week.

Probably not a fit

Patients with significant health issues that prevent them from engaging in physical activity or those who are already meeting physical activity guidelines may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to enhance physical activity adherence among midlife adults by testing various goal-setting techniques. It focuses on individuals aged 45 to 65 with obesity who currently engage in minimal physical activity. The study will employ a two-phased approach, starting with a pilot phase to establish feasibility, followed by a proof-of-concept trial to evaluate the effectiveness of the interventions over nine months. The ultimate goal is to promote regular physical activity to reduce the risk of Alzheimer's disease and related dementias.

Why it matters

Potential benefit: If successful, this study could lead to improved physical activity levels in midlife adults, potentially reducing their risk of Alzheimer's disease and related dementias.

How similar studies have gone: Other studies have shown promise in using goal-setting techniques to enhance physical activity adherence, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 45 to 65 years
* BMI between 30 kg/m2 to 50 kg/m2
* Participants must weigh a minimum of 110 pounds
* Engaging in 60 minutes or less of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire)
* Self-reported ownership of a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a Fitbit activity monitor)

Exclusion Criteria:

* Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided
* Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided)
* Pregnant or planning to become pregnant in next 8-months (Phase 1) or 12 months (Phase 2)
* Plans to relocate out of metropolitan Phoenix, Arizona area in the next 8-months (Phase 1) or 12 months (Phase 2)
* Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention
* Individuals with mild cognitive impairment (MCI), as determined by either a self-report of receiving a diagnosis of MCI from a health care provider or as assessed by the Montreal Cognitive Assessment (MoCA) at the study orientation session. A score \< 26 is an exclusion criterion for US born participants. A score of \<23 is an exclusion for participants born outside of the US who completed their high school education in a country where English is not the primary language.
* Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric)
* Score of 16 or higher on the Center for Epidemiological Studies-Depression Scale (CES-D)
* Self-reported current diagnosis of major depression
* Currently taking 2 or more ant-depression drugs
* History of stroke
* Incarcerated individuals (i.e., Prisoners)

Where it's running

  • Arizona State University
    Phoenix, Arizona, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.